tirzepatide cardiovascular outcome Real-world efficacy of in patients with heart failure without diabetes Network meta-analysis league tables comparing

Learn more about Zepbound to get started

These are not theoretical risks - they are documented safety concerns that underscore why the choice between compounded and FDA-approved medications should be made carefully with your prescribing clinician, who can discuss the specific pharmacy and quality assurance protocols involved in your prescription

Other weight loss drugs of a similar class, but even more effective, are under development and can be expected to sell out quickly when they come on the market

doi: 10.1056/NEJMoa2206038

Mounjaro has not been studied in patients with a prior history of pancreatitis

The long half-life (approximately five days) maintains stable blood levels with weekly dosing